And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, it so happens, is exceedingly modest. We hope to catch up on our reading, take a few constitutional strolls, and nap as often as possible. And what about you? This may be an opportunity to plan a holiday getaway or stimulate the economy by shopping for a few gifts. Or you could take stock and be happy you are not about to be impeached. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.

Prices for prescription drugs edged down by 1% last year, a rare result driven by declines for generics and slow, low growth in the cost of brand-name medications, the Associated Press reports, citing government data. Though modest, it was the first such price drop in 45 years. The price drop was for retail pharmacy prescriptions, not medications administered in hospitals or doctor’s offices. The last time retail prescription drug prices declined was in 1973, when they went down by 0.2%.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy